Chuling Fang
Overview
Explore the profile of Chuling Fang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang L, Fang C, Kang Q, Huang W, Chen Z, Zhao W, et al.
Blood Cancer J
. 2024 Aug;
14(1):130.
PMID: 39112452
Non-Hodgkin lymphoma (NHL) is a common malignancy in the hematologic system, and traditional therapy has limited efficacy for people with recurrent/refractory NHL (R/R NHL), especially for patients with diffuse large...
2.
Wang L, Pang Y, Fang C, Zhao W, Xu Y, Guo X, et al.
Medicine (Baltimore)
. 2023 Dec;
102(50):e36397.
PMID: 38115347
Rationale: Mixed phenotype acute leukemia (MPAL) is a rare and heterogeneous type of leukemia known for its poor prognosis. The optimal treatment strategy for this condition currently lacks consensus, leaving...
3.
Fang C, Chen Z, Li J, Yu L, Wang L
AME Case Rep
. 2023 Nov;
7:37.
PMID: 37942038
Background: Chronic myelomonocytic leukemia (CMML) is a rare, malignant, clonal hematopoietic disorder with features of both myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN). It is classified as MDS/MPN overlap syndrome...
4.
Liu T, Gonzalez De Los Santos F, Rinke A, Fang C, Flaherty K, Phan S
Front Immunol
. 2022 Sep;
13:901349.
PMID: 36045668
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease without effective curative therapy. Recent evidence shows increased circulating myeloid-derived suppressor cells (MDSCs) in cancer, inflammation, and fibrosis, with some...
5.
Zhang Q, Huang H, Zhang M, Fang C, Wang N, Jing X, et al.
Front Oncol
. 2022 Jul;
12:910227.
PMID: 35860586
Background: Sarcoidosis is an inflammatory disease characterized by non-caseating granuloma formation in various organs, with several recognized genetic and environmental risk factors. Despite substantial progress, the genetic determinants associated with...
6.
Jing X, Sun W, Yang X, Huang H, Wang P, Luo Q, et al.
Int J Biochem Cell Biol
. 2021 Dec;
143:106142.
PMID: 34954323
Alveolar epithelial cell senescence is a core event in the development of pulmonary fibrosis. Endoplasmic reticulum stress accelerates cellular senescence significantly; however, whether this stress promotes alveolar epithelial cell senescence...
7.
Fang C, Rinke A, Wang J, Flaherty K, Phan S, Liu T
J Pathol
. 2021 Nov;
256(3):310-320.
PMID: 34825713
The clinical significance of B7H3 (CD276) and its cleavage product soluble B7H3 (sB7H3) in idiopathic pulmonary fibrosis (IPF) is unknown. Mounting evidence suggests the potential utility of peripheral blood myeloid...
8.
Fang C, Huang H, Feng Y, Zhang Q, Wang N, Jing X, et al.
Sci Rep
. 2021 Jan;
11(1):1443.
PMID: 33446833
Genetic factors play a role in the risk of idiopathic pulmonary fibrosis (IPF). Specifically, MUC5B rs35705950 non-risk alleles and immunologic aberrations were associated with the IPF's progression. However, rare genetic...
9.
Fang C, Huang H, Zhang Q, Wang N, Jing X, Guo J, et al.
Respirology
. 2020 Jun;
25(12):1265-1273.
PMID: 32583532
Background And Objective: IPF is an ageing-related lung disorder featuring progressive lung scarring. IPF patients are frequently identified with short telomeres but coding mutations in telomerase can only explain a...
10.
Fang C, Zhang Q, Wang N, Jing X, Xu Z
Sarcoidosis Vasc Diffuse Lung Dis
. 2020 Jun;
36(3):217-227.
PMID: 32476957
Background: Pulmonary sarcoidosis patients who get disease progression despite corticosteroid treatment or can't tolerate corticosteroid required second-line drug. Methotrexate (MTX) is the most widely used in our clinical practice. Data...